From February 5, 2024 to March 31, 2024, the company has repurchased 994,500 shares, representing 1.24% for CNY 19.99 million. With this, the company has completed the repurchase of 994,500 shares, representing 1.24% for CNY 19.99 million under the buyback announced on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.34 CNY | +0.26% | -0.67% | -27.48% |
1st Jan change | Capi. | |
---|---|---|
-27.48% | 211M | |
+37.74% | 723B | |
+34.11% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.02% | 244B | |
+9.80% | 208B | |
-4.46% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.